Targeted degradation of protein in hematologic malignancies: mechanisms, therapeutic strategies, and clinical prospects

Sana Nafees, Glowi Alasiri, Mohammad Suhail Akhter, Nemat Ali

Open source

DOI
10.1038/s41417-026-01082-z
Published
2026-09-22
Container
Cancer Gene Therapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41417-026-01082-z,
  title = {Targeted degradation of protein in hematologic malignancies: mechanisms, therapeutic strategies, and clinical prospects},
  author = {Sana Nafees and Glowi Alasiri and Mohammad Suhail Akhter and Nemat Ali},
  year = {2026},
  journal = {Cancer Gene Therapy},
  doi = {10.1038/s41417-026-01082-z},
  url = {https://doi.org/10.1038/s41417-026-01082-z}
}

RIS

TY  - JOUR
TI  - Targeted degradation of protein in hematologic malignancies: mechanisms, therapeutic strategies, and clinical prospects
AU  - Sana Nafees
AU  - Glowi Alasiri
AU  - Mohammad Suhail Akhter
AU  - Nemat Ali
PY  - 2026
JO  - Cancer Gene Therapy
DO  - 10.1038/s41417-026-01082-z
UR  - https://doi.org/10.1038/s41417-026-01082-z
ER  - 

APA

Nafees, S., Alasiri, G., Akhter, M. S., & Ali, N. (2026). Targeted degradation of protein in hematologic malignancies: mechanisms, therapeutic strategies, and clinical prospects. Cancer Gene Therapy. https://doi.org/10.1038/s41417-026-01082-z

Source records